Eton Pharmaceuticals Stock Price on November 11, 2024
| ETON Stock | USD 12.03 0.80 7.12% |
Below is the normalized historical share price chart for Eton Pharmaceuticals extending back to November 13, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Eton Pharmaceuticals stands at 12.03, as last reported on the 26th of November, with the highest price reaching 12.33 and the lowest price hitting 11.37 during the day.
If you're considering investing in Eton Stock, it is important to understand the factors that can impact its price. Eton Pharmaceuticals is somewhat reliable given 3 months investment horizon. Eton Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.39, which denotes the company had a 0.39% return per unit of risk over the last 3 months. We were able to break down and interpolate data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.59% are justified by taking the suggested risk. Use Eton Pharmaceuticals Mean Deviation of 2.67, coefficient of variation of 255.44, and Downside Deviation of 3.09 to evaluate company specific risk that cannot be diversified away.
As of the 26th of November 2024, Total Stockholder Equity is likely to drop to about 12.7 M. In addition to that, Common Stock Total Equity is likely to drop to about 20 K. At this time, Eton Pharmaceuticals' Price Fair Value is very stable compared to the past year. Eton Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 13th of November 2018 | 200 Day MA 4.5932 | 50 Day MA 6.9582 | Beta 1.257 |
Eton |
Sharpe Ratio = 0.3931
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ETON | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.05 actual daily | 36 64% of assets are more volatile |
Expected Return
| 1.59 actual daily | 31 69% of assets have higher returns |
Risk-Adjusted Return
| 0.39 actual daily | 30 70% of assets perform better |
Based on monthly moving average Eton Pharmaceuticals is performing at about 30% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Eton Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 19.4487 | Enterprise Value Ebitda 51.2617 | Price Sales 9.9044 | Shares Float 21.7 M | Wall Street Target Price 13 |
Related Headline
Nuvation Bio Headline on 11th of November 2024
Disposition of 56361 shares by Junyuan Wang of Nuvation Bio ... by Junyuan Wang
Filed transaction by Nuvation Bio Director, Officer: Ceo, Anheart Therapeutics Ltd.. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Eton Pharmaceuticals Valuation on November 11, 2024
It is possible to determine the worth of Eton Pharmaceuticals on a given historical date. On November 11, 2024 Eton was worth 8.78 at the beginning of the trading date compared to the closed value of 9.71. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Eton Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Eton Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Eton Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Eton Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 8.71 | 8.97 | 8.62 | 8.78 | 170,080 | |
11/11/2024 | 8.78 | 9.88 | 8.78 | 9.71 | 575,150 |
| 9.60 | 9.70 | 8.76 | 9.17 | 290,608 |
| Backtest Eton Pharmaceuticals | | | Eton Pharmaceuticals History | | | Eton Pharmaceuticals Valuation | Previous | Next |
Eton Pharmaceuticals Trading Date Momentum on November 11, 2024
| On November 12 2024 Eton Pharmaceuticals was traded for 9.17 at the closing time. The top price for the day was 9.70 and the lowest listed price was 8.76 . The trading volume for the day was 290.6 K. The trading history from November 12, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 5.56% . The overall trading delta against the current closing price is 5.46% . |
Eton Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Eton Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Eton Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Eton financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Eton Pharmaceuticals Stock history
Eton Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Eton is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Eton Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Eton Pharmaceuticals stock prices may prove useful in developing a viable investing in Eton Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 25.6 M | 21.6 M | |
| Net Loss | -10.4 M | -10.9 M |
Eton Pharmaceuticals Quarterly Net Working Capital |
|
Eton Pharmaceuticals Stock Technical Analysis
Eton Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Eton Pharmaceuticals Period Price Range
Low | November 26, 2024
| High |
0.00 | 0.00 |
Eton Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Eton Pharmaceuticals November 26, 2024 Market Strength
Market strength indicators help investors to evaluate how Eton Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Eton Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Eton Pharmaceuticals stock market strength indicators, traders can identify Eton Pharmaceuticals entry and exit signals to maximize returns
Eton Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Eton Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Eton Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Eton to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.3073 | |||
| Jensen Alpha | 1.4 | |||
| Total Risk Alpha | 0.9329 | |||
| Sortino Ratio | 0.4638 | |||
| Treynor Ratio | 1.23 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Eton Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. To learn how to invest in Eton Stock, please use our How to Invest in Eton Pharmaceuticals guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eton Pharmaceuticals. If investors know Eton will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eton Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.13) | Earnings Share (0.26) | Revenue Per Share 1.219 | Quarterly Revenue Growth (0.24) | Return On Assets (0.12) |
The market value of Eton Pharmaceuticals is measured differently than its book value, which is the value of Eton that is recorded on the company's balance sheet. Investors also form their own opinion of Eton Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Eton Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eton Pharmaceuticals' market value can be influenced by many factors that don't directly affect Eton Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Eton Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Eton Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eton Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.